Paul Tudor Jones Abb Vie Inc. Transaction History

Tudor Investment Corp Et Al

$19.2 Billion
Q2 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Abb Vie Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 25,400 shares of ABBV stock, worth $4.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

25,400

Previous 82,300 69.14%

Holding current value

$4.95 Million

Previous $15 Million 70.93%

% of portfolio

0.02%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $6.84 Million - $7.7 Million	49,699 Added 391.39%	62,397 $9.67 Million
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $19.3 Million - $22.4 Million	-144,587 Reduced 91.93%	12,698 $1.89 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $20.8 Million - $25.9 Million	157,285 New	157,285 $21.2 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $285,062 - $326,947	2,124 Added 25.09%	10,591 $1.42 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.17 Million - $1.48 Million	8,467 New	8,467 $1.3 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $5.18 Million - $6.43 Million	-39,268 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.55 Million - $3.22 Million	23,690 Added 152.07%	39,268 $5.32 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $2.14 Million - $2.43 Million	-20,146 Reduced 56.39%	15,578 $1.68 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.97 Million - $2.2 Million	18,770 Added 110.71%	35,724 $4.02 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.73 Million - $1.91 Million	16,954 New	16,954 $1.84 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $3.88 Million - $5.24 Million	-48,175 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $4.14 Million - $4.86 Million	48,175 New	48,175 $4.22 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $2.96 Million - $3.96 Million	-40,340 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $450,016 - $682,280	-6,977 Reduced 14.75%	40,340 $3.07 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $3.41 Million - $4.27 Million	47,317 New	47,317 $4.19 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.54 Million - $3.24 Million	-38,614 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $2.98 Million - $3.51 Million	38,614 New	38,614 $3.11 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $9.81 Million - $12.1 Million	-125,972 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $2.06 Million - $2.29 Million	-23,195 Reduced 15.55%	125,972 $11.9 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $5.67 Million - $6.7 Million	63,113 Added 73.34%	149,167 $13.8 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $7.92 Million - $10.6 Million	86,054 New	86,054 $8.15 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account